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Abstract 
Obesity results from a disruption of normal energy homeostasis, and leads to a state of chronic 
low-grade inflammation. Given that inflammatory cytokines can disrupt synaptic activity and that 
obesity has been shown to cause cognitive impairment, I hypothesized that diet-induced obesity 
may cause an inflammatory response in regions of the brain important for learning and memory. 
Notably, previous diet-induced obesity studies have tended to focus on male animals, but sexual 
dimorphism in response to a high-fat diet (HFD) has been suggested; as a result, female rats were 
randomly assigned to either a control diet (CD; 10% kcal from fat), or a HFD (45% kcal from fat) 
at post-natal day 28. After 10 weeks, the hippocampus and pre-frontal cortex were extracted from 
each animal and homogenized. Immunoblotting was used to determine if a HFD affected levels of 
pro/anti-inflammatory cytokines, glial cells, and proteins involved in leptin signal transduction. A 
HFD was found to cause enhanced expression of anti-inflammatory IL-1ra in the prefrontal cortex, 
but no cytokine-related changes in the hippocampus (although levels of the leptin receptor and 
AKT/PKB were reduced in the hippocampus, but not the pre-frontal cortex). Although the data 
demonstrate that our protocol did not induce obvious proinflammatory changes, the possibility 
exists that the elevated IL-1ra levels reflect a compensatory response to an earlier period of 
inflammation caused by the HFD. Future work should expand on my current findings with the 
inclusion of male animals to allow for a direct sex comparison of the effects of the HFD. Our 
model could also be expanded with an immune challenge via lipopolysaccharide injection, or 
leptin stimulation in order to tease out potential differences not observed under basal conditions. 
Transgenerational effects should also be explored by examining the effects a maternal HFD may 
have on the expression of similar proteins in the offspring.  
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1.0 Introduction 
Although the true definition of obesity is often not clear, obesity may be broadly defined 
as the accumulation of a level of body fat sufficient to cause negative health outcomes (Heshka & 
Allison, 2001; Allison et al., 2008). Obesity can be operationally defined by utilizing a simple ratio 
of weight to height, where individuals are considered overweight if they attain a body-mass index 
(BMI) between 25.0 – 29.9 kg/m2, and obese if their BMI is 30 kg/m2, or more (Heshka & Allison, 
2001; Allison et al., 2008). Factors such as genetic predisposition play a role in the rise of 
individuals diagnosed with obesity, but one of the largest environmental factors is likely the 
chronic overconsumption of the Western diet (foods consisting of high levels of sugar and fat), 
and reduced physical activity (Kanoski & Davidson, 2011). Collectively, these factors lead to an 
alteration in normal metabolism and hormonal function, resulting in the early onset of obesity, 
which then increases one’s risk for the development of related co-morbidities, such as type II 
diabetes mellitus, cardiovascular disease, and cancer (Heshka & Allison, 2001; Allison et al., 2008; 
Kanoski & Davidson, 2011). 
Another important aspect of obesity that is starting to gain attention is its effect upon 
cognition (Kanoski & Davidson, 2011). In a longitudinal study by Whitmer et al. (2005), 
overweight middle aged adults were 1.35 times more likely to be diagnosed with dementia 
compared to their normal weight counterparts, while age matched obese individuals were 1.74 
times more likely to be diagnosed. Similarly, Gunstad et al. (2006) found an inverse relationship 
between BMI and verbal memory performance across the adult lifespan. Obesity-induced 
cognitive impairments can also be recreated experimentally using animal models, where animals 
fed a high-fat and/or high-sucrose diet show impairments in a variety of memory related 
behavioural tasks (Pistell et al., 2010; Beiharz et al, 2014; Boitard et al., 2014). Despite the 
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significance of diet-induced cognitive impairment, the underlying neurophysiological mechanisms 
are still poorly understood.  The hippocampus and the pre-frontal cortex have been the target of 
much diet related memory research due to their involvement with long-term/spatial memory 
formation and cognitive flexibility, as well as their susceptibility to environmental insults (Kanoski 
& Davidson, 2011; Preston & Eichenbarum, 2013). This thesis document will review the literature 
regarding how obesity, particularly when caused by a high-fat diet, can affect hippocampal and 
pre-frontal cortical function. After a description and discussion of the connections between diet-
induced obesity and behaviour, experiments were completed to expand our current knowledge 
about how obesity may affect neuronal function will be provided.  
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2.0 Literature Review 
2.1 Obesity and Brain Function 
2.1.1 The Hippocampus and the Pre-frontal Cortex: Structure and Function  
 The hippocampus is a bilateral limbic structure located in the medial temporal lobe, and 
can be divided into two major regions: the dentate gyrus, consisting primarily of granule cells, and 
the Cornu Ammonis (CA), consisting primarily of pyramidal cells (Neves et al., 2012). The flow 
of information within the hippocampus is typically described as a tri-synaptic circuit (Neves et al., 
2012). Information travels from the entorhinal cortex into the dentate gyrus through the perforant 
path. Granule cells in the dentate gyrus project their axons toward the pyramidal neurons in the 
CA3 region through the mossy fibers, which, in turn, project onto the ipsilateral CA1 pyramidal 
cells through the Schaffer collaterals (Neves et al., 2012). Afterwards, signals are directed back to 
the entorhinal cortex, and then to other brain areas (Preston & Eichenbarum, 2013).  
The pre-frontal cortex is the region of the cerebral cortex that covers the anterior part of 
the frontal lobe and receives projections from the hippocampus into its rostroventral region 
(Preston & Eichenbarum, 2013). Without proper maintenance of the hippocampal-prefrontal 
cortical neuronal network, dysfunction of either brain region can negatively impact the function of 
the other (Preston & Eichenbarum, 2013). Therefore, while the hippocampus is primarily 
responsible for consolidation of information from short term into long term memory and spatial 
navigation, it also has an indirect role in mediating pre-frontal cortical behaviours, such as 
executive function, working memory, attentional control, cognitive flexibility, and behavioural 
inhibition (especially of those related to the reward system) (Neves et al., 2012; Preston & 
Eichenbarum, 2013). Other brain regions that project to the hippocampus and the pre-frontal cortex 
include the amygdala and the hypothalamus, suggesting that the hippocampus and the pre-frontal 
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cortex also serve a role in mediating emotional regulation and the stress response (Kanoski & 
Davidson, 2011; Neves et al., 2012). See Figure 1 for a schematic map of the connected brain 
areas. 
2.1.2 High-Fat Diet and Animal Behaviour 
In order to closely study the effects of obesity on animal cognition, a high-fat diet (HFD) 
feeding protocol is often used (Kanoski & Davidson, 2011). Animal models have provided 
evidence of the effects of a HFD on hippocampal-dependent behavioural tasks, most commonly 
tested through spatial memory performance on the Morris water maze, or a novel place recognition 
task (Mielke et al., 2006; Pistell et al., 2010; Beiharz et al., 2014; Boitard et al., 2014). Beilharz et 
al. (2014), for example, were able to show that short term exposure to a HFD affects mainly the 
hippocampus in male Sprague-Dawley rats, based on behavioural impairment being observed in a 
place recognition task, where time spent interacting with a familiar object placed in a novel 
location was measured. On the other hand, diet had no effect on performance in the novel object 
recognition task, where animals were measured on time spent interacting with a novel object in a 
familiar location (Beilharz et al., 2014). Further evidence for the effects of a HFD was found by 
Boitard et al. (2014), who demonstrated that HFD impaired long term memory in male Wistar rats 
after 1-2 months of exposure when tested via the probe trials of the Morris water maze, indicating 
impairments in the ability to recall a previously acquired spatial learning memory.  
Similar deficits were found with HFD-fed (60% of calories from fat) mice used in a study 
conducted by Pistell et al. (2010), where significantly more errors were observed in male mice in 
the Stone T-maze, another test for spatial ability and cognition. However, no effect was seen when 
this group used a less intensive HFD (41% of calories from fat with an additional 29% of calories 
from sucrose) (Pistell et al. 2010). Male C57BL/6 mice used by Mielke et al (2006) showed no 
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significant differences in performance in the water maze during the memory acquisition phase 
(indicated by the animal’s ability to learn where a hidden platform is in the Morris water maze) 
after 5 months and 10 months on the diet, suggesting that the hippocampus was not affected. On 
the other hand, mice fed the HFD were unable to complete an operant-learning task, which was as 
an alternate measure of hippocampal memory acquisition where animals needed to learn to press 
a bar to gain access to their food (Mielke et al., 2006).  
Pre-frontal cortical-dependent behaviours are most commonly tested through reversal 
training, where animals must learn to extinguish a previously learnt behaviour in order to acquire 
a new one (Kanoski et al., 2007). Evidence for pre-frontal cortical dependent behaviours can be 
seen in the results from Kanoski et al. (2007) and their discrimination reversal task where trained 
male Sprague-Dawley rats had to learn to respond to a new conditioned stimulus. In their study, 
animals fed a HFD supplemented with dextrose over a 90 day period performed significantly worse 
compared to animals on the control diet (CD). Interestingly, these deficits were abolished when 
animals had restricted access to their food, instead of ad libitum access (Kanoski et al., 2007). 
Although, in general, animals given a HFD perform worse in behavioural tasks than CD animals, 
the variability between feeding protocols, makes the results difficult to compare. See Table 1 for 
a summary of several different protocols used by different authors. 
In order to gain a better understanding of the potential mechanisms underlying the effect 
obesity has on hippocampal and pre-frontal cortical function, researchers often accompany 
behavioural experiments with various biochemical tests to probe for changes in factors that can 
directly, or indirectly, impact these brain regions. However, the link between diet-induced 
cognitive deficits and specific biomarkers is weak, since obesity has been connected to many 
physiological conditions that can have a negative impact on the brain (Kanoski & Davidson, 2011; 
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Neves et al., 2012). The majority of the literature has focused on processes that impair synaptic 
plasticity, such as reduced neurogenesis, neuroinflammation, and altered hormonal signaling in 
the form of insulin and leptin resistance (Kanoski & Davidson, 2011; Miller & Spencer, 2014). 
Together, these cognitive impairments can act as both a cause and a consequence of obesity; that 
is, with reduced hippocampal and pre-frontal cortical function, individuals may become more 
prone to obesity-related behaviours, such as greater food intake, overeating, and less physical 
activity (Myers et al, 2006; Kanoski & Davidson, 2011).  
2.2 Obesity and Inflammation 
2.2.1 Obesity and Chronic Inflammation 
Obesity has been characterized as a state of low-grade chronic inflammation (Monteiro & 
Azevedo, 2010), which, in turn, can have a number of effects on cognitive function (Lumeng & 
Saltiel, 2011; Miller & Spencer, 2014). There are a variety of factors that can contribute to obesity-
induced inflammation, one of which is the accumulation of saturated fatty acids leading to greater 
activation of Toll-like receptors 2 and 4 (TLR2; TLR4), which normally detect pathogens and 
activate the innate immune system upon detecting foreign substances, such as lipopolysaccharides 
(LPS) from Gram-negative bacteria (Lumeng & Saltiel, 2011; Miller & Spencer, 2014). Saturated 
fatty acids appear to act on TLR2 and TLR4 in a manner similar to LPS (Lumeng & Saltiel, 2011; 
Miller & Spencer, 2014). Upon activation, TLRs can lead to greater metabolic stress, especially in 
the endoplasmic reticulum, which results in higher production of unfolded proteins and 
mitochondrial dysfunction (Lumeng & Saltiel, 2011; Miller & Spencer, 2014). With the 
accumulation of reactive oxygen species and inflammation, cells become damaged and are lost 
from excessive TLR stimulation (Monteiro & Azevedo, 2010; Kanoski & Davidson, 2011; 
Lumeng & Saltiel, 2011; Miller & Spencer, 2014). 
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2.2.2 Inflammatory Cytokines 
TLR activation can also initiate the production of inflammatory cytokines. Cytokines are a 
group of low-molecular weight, non-antibody polypeptides that mediate cellular 
intercommunication via autocrine, paracrine, or endocrine mechanisms (Wilson et al, 2002; 
Lyman et al. 2014). Various cells can secrete cytokines, but their transcription is highly controlled 
and they bind only to specific receptors to form complex networks with a high degree of 
pleiotropism (Wilson et al., 2002; Lyman et al., 2014). Cytokines may be classified based on their 
role in the body: proinflammatory, anti-inflammatory, or involved in hematopoiesis (Wilson et al., 
2002; Lyman et al., 2014). Chemokines, such as monocyte attractant protein 1 (MCP-1), are a 
subset of cytokines with chemotactic properties responsible for recruiting immune cells to the site 
of inflammation (Wilson et al., 2002; Lyman et al., 2014). Through the communication of various 
cytokines, a number physiological changes, both locally and systemically, can be induced by 
mediating the innate and adaptive arms of the immune system to produce a suitable response to 
the threat at hand (Wilson et al., 2002; Lyman et al., 2014).  
Expression of proinflammatory cytokines, such as interleukin-1 (IL-1), interleukin-6 (IL-
6), and tumor necrosis factor alpha (TNFα), are usually initiated by detection and recognition of a 
foreign particulate, such as LPS, or tissue damage (Wilson et al., 2002; Lyman et al., 2014). 
Notably, although IL-6 is mostly regarded as a proinflammatory cytokine, alternate signaling 
properties of IL-6 can also induce anti-inflammatory effects (classical signaling rather than trans-
signaling of IL-6), making IL-6 a pleiotropic cytokine (Scheller et al., 2011). Stimulation induces 
the rapid synthesis of cytokines, which are packaged into secretory vesicle or endosomes by the 
endoplasmic reticulum-Golgi complex, and then released by means of conventional secretion, 
shedding of plasma microvesicles, or cell lysis (Stanley & Lacy, 2010; Lopez-Castejon & Brough, 
8 
 
2011). However, other cytokines like IL-1, which are initially synthesized in an inert pro-form, 
may require further processing, like proteolytic cleavage to its mature active form, before being 
secreted (Stanley & Lacy, 2010; Lopez-Castejon & Brough, 2011). Collectively, the 
proinflammatory cytokines secreted result in physiological changes, such as vasodilation, 
swelling, clotting to contain the particulate, recruitment of additional immune cells, and activation 
of immune cells to clear the foreign particulate (Wilson et al., 2002; Lyman et al., 2014). Upon 
clearing the foreign substance, inflammation is then diminished by anti-inflammatory cytokines, 
such as interleukin-10 (IL-10) and interleukin-1 receptor antagonist (IL-1ra), which inactivate the 
immune cells to return the body to a state of homeostasis and reduce damage to nearby cells that 
may occur through excessive immune activity and reactive oxygen species production (Wilson et 
al., 2002; Lyman et al., 2014). Since the inflammatory process is highly regulated, subtle shifts in 
cytokine expression can have dramatic effects on the body (Wilson et al., 2002; Lyman et al., 
2014). Obese individuals, for example, typically display a greater presence of basal 
proinflammatory cytokines, such as IL-6, TNFα, and MCP-1, and elevated levels of acute phase 
proteins, such as C-reactive protein (CRP), indicating a tonic-grade activation of the immune 
system (Martin et al., 2008; Monteiro & Azevedo, 2010; Lyman et al., 2014).  
During the progression of obesity, enlarged adipocytes become another contributing factor 
to the state of inflammation. In addition to their role following infection and injury, IL-1, IL-6, 
and TNFα are also common adipokines; cytokines which are secreted by adipocytes and not solely 
by immune cells (Myers et al., 2007; Martin et al., 2008). As the level of adipose tissue grows, due 
to the overconsumption of a HFD, so too do the levels of proinflammatory cytokines secreted into 
the circulation (Monterio & Azevedo, 2010; Lumeng & Saltiel, 2011). The proinflammatory state 
is accompanied by an enhanced migration of macrophages and monocytes into the white adipose 
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tissue, and leads to greater communication between immune cells and metabolic cells (Lumeng & 
Saltiel, 2011). In fact, an estimated 20-30 million macrophages accumulate in each kilogram of 
excess fat in humans, and these can lead to downstream effects, such as dysfunction in normal 
insulin and leptin signaling, which can promote lipid storage and suppress lipid metabolism 
(Lumeng & Saltiel, 2011). Expanding adipocytes are also more prone to rupture, leading to the 
release of reactive oxygen species, resulting in even greater production of IL-6, TNFα, and CRP, 
thus perpetuating the state of inflammation (Monteiro & Azevdeo, 2009). As a result, in response 
to a HFD, the immune system will become chronically stimulated, resulting in systemic 
inflammation that can lead to disruption and damage to nearby cells that further deteriorates the 
health of the obese individual (Monteiro & Azevdeo, 2009; Lumeng & Sailtiel, 2014).  
2.2.3 Obesity and Neuroinflammation 
Considering the link between obesity and systemic inflammation, it is not surprising that 
inflammation can also affect the central nervous system (CNS) in obese individuals (Cai, 2013; 
Miller & Spencer, 2014). Normally, the blood-brain barrier (BBB), a specialized microvascular 
endothelium, limits the entry of many blood components in the periphery from entering the CNS 
(Cai, 2013; Miller & Spencer, 2014). However, the integrity of the BBB has been shown to be 
compromised during intake of high-energy diets, especially in aged obese animals (Kanoski et al., 
2010; Tucsek et al., 2014). Immune factors derived from diet-induced systemic inflammation, such 
as inflammatory cytokines, prostaglandin, and CRP, can contribute to increased permeability of 
the BBB by altering tight junctions in endothelial cells in the brain vasculature (Lyman et al., 2014; 
Miller & Spencer, 2014; Hsuchou et al., 2012). Inflammatory cytokines from the periphery can 
also be transported into the brain through circumventricular organs, regions of the brain that are 
highly vascularized and lack a complete BBB (Lyman et al., 2014; Miller & Spencer, 2014; 
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Hsuchou et al., 2012). With the BBB compromised, leukocytes and inflammatory cytokines from 
the periphery can readily enter the brain to initiate a proinflammatory cascade (Lyman et al. 2014; 
Miller & Spencer, 2014). As well, saturated fatty acids can act on the TLR4 of microglia and 
astrocytes to elicit an immune response similar to that caused by LPS interaction with TLR4s in 
the periphery (Lyman et al. 2014; Miller & Spencer, 2014). Activated glial cells, primarily 
stimulated microglia, secrete inflammatory cytokines, nitric oxide, and prostaglandin converted 
from arachidonic acid to further promote the state of inflammation and endoplasmic reticulum 
stress, even at the neuronal level (Lyman et al. 2014; Miller & Spencer, 2014).  
Neuroinflammation due to cytokine production and recruitment of peripheral macrophages 
can disrupt normal physiological processes in the CNS (Lyman et al. 2014; Miller & Spencer, 
2014). Neurons in the midst of a proinflammatory milieu can experience unregulated and excessive 
activity, resulting in excitoxicity and neurodegeneration (Yirmiya & Goshen, 2011).  For example, 
as a result of HFD, inflammation of the hypothalamus is linked to hypothalamic-pituitary-adrenal 
(HPA) axis dysfunction, which, in turn, disrupts normal feeding and metabolic regulation via 
disruption of insulin and leptin signaling in the periphery (Cai, 2013; Lyman et al., 2014; Miller 
& Spencer, 2014). Neuroinflammation can also extend into the hippocampus and pre-frontal 
cortex, causing gliosis and neuronal damage (Miller & Spencer, 2014). For example, ionized 
calcium-binding adaptor molecule 1 (Iba-1) is commonly used as a marker for microgliosis and is 
involved with the remodeling of the actin cytoskeleton that allows for motility, proliferation, and 
phagocytosis in activated microglia (Imai & Kohsaka, 2002). Glial fibrillary acidic protein 
(GFAP), on the other hand, is used as a marker for astrogliosis as it is the main intermediate 
filament protein expressed in mature astrocytes and is involved in cell motility, proliferation, 
vesicle trafficking, and controlling neuronal outgrowth (Middledorp & Hol, 2011). Over time, 
11 
 
chronic activation of microglia can lead to abnormal synaptic remodeling as microglia serve a role 
in synaptic pruning via fractalkine (CX3CL1) mediated phagocytosis while hypertrophy of 
reactive astrocytes can disrupt neuronal networks through the formation of compact glial scar 
tissues (Palicelli et al. 2011; Sofroniew & Vinter, 2010).  
Inflammation mediated by cytokines is also a hallmark of cognitive dysfunction that 
negatively impacts neuronal plasticity (McAfoose & Baune, 2009). For example, proinflammatory 
IL-1β has been shown to have an inverted “U” relationship with hippocampal dependent memory 
and synaptic plasticity. At low physiological levels, IL-1 expression can assist with the 
maintenance of long term potentiation (LTP), an example of synaptic plasticity in neurons, and a 
cellular model for learning and memory (Goshen et al., 2007; McAfoose & Baune, 2009). 
However, both insufficient IL-1 signaling and high concentrations of IL-1, such as those seen with 
aging, stress, and disease, can cause inhibition of both LTP and fear conditioning memory (Goshen 
et al., 2007; McAfoose & Baune, 2009). Similarly, pleiotropic IL-6 appears to have a role 
governing LTP by opposing the action of IL-1 (Balschun et al., 2003; McAfoose & Baune, 2009). 
Under physiological conditions, IL-1 and IL-6 oppose one another in terms of LTP maintenance, 
as a means to fine-tune long-term plasticity and hippocampal dependent learning (Balschun et al., 
2003; McAfoose & Baune, 2009). However, an elevation of IL-6 is highly correlated with age-
related memory disturbance (Yirmiya & Goshen, 2011).  
Gene expression data taken from the hippocampus and the pre-frontal cortex collected by 
Boitard et al (2014), revealed no differences between IL-1β, IL-6, or TNFα expression at a basal 
level between CD and HFD animals. However, when given an immune challenge (intraperitoneal 
LPS injections), animals on the HFD were more sensitive and displayed enhanced production of 
IL-1β and TNFα relative to CD rats; notably, this enhanced immune response was not observed in 
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adult animals, suggesting that there is a window of vulnerability to the adverse effects of HFD on 
hippocampal function (Boitard et al., 2014). Baumgarner et al. (2014) revealed the opposite trend 
where HFD mice were less sensitive to LPS induced expression of IL-1β and IL-6 mRNA in the 
hippocampus, suggesting that the impairments in spatial memory they also observed in these 
animals were likely not due to alterations in the immune system. Instead, they found that HFD 
mice showed significantly reduced brain derived neurotrophic factor (BDNF), synaptophysin, and 
post-synaptic density-95 (PSD-95) mRNA expression, indicating a reduction in neurotrophic 
support and impaired synaptic activity (Baumgarner et al., 2014). Even with the absence of an 
immune challenge, Pistell et al. (2010) showed that as one raises the fat content from 41% of 
calories to 60% of calories, basal protein levels of GFAP, Iba-1, TNFα, IL-6, and MCP-1 become 
elevated in the whole brain, accompanied by reduced BDNF protein expression in HFD mice 
relative to their CD counterparts. While the study conducted by Kanoski et al. (2007) did not assess 
cytokines, they found evidence of how an energy dense diet can negatively impact the 
hippocampal-prefrontal cortical circuitry, which they attribute to a neuroinflammatory mechanism 
after finding reduced protein expression of BDNF in the ventral hippocampus and the pre-frontal 
cortex.  
2.3 Obesity and Leptin Resistance 
2.3.1 Leptin and its Receptor (Ob-R) 
Concurrent with the onset of inflammation in obese individuals is the development of leptin 
resistance (Otero et al., 2005; Martin et al., 2008; Irving & Harvey, 2014). Leptin is a 16-kDa 
polypeptide hormone primarily produced by white adipose tissue (Otero et al., 2005; Martin et al., 
2008). Leptin and its receptor, Ob-R, are encoded by the ob gene and they serve a role in mediating 
energy homeostasis (Otero et al., 2005; Martin et al., 2008; Irving & Harvey, 2014). As one eats, 
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the accumulation of excessive calories and fatty acids in adipose tissue releases adipokines, such 
as leptin, to regulate and maintain a normal body weight (Otero et al., 2005; Martin et al., 2008; 
Irving & Harvey, 2014). 
The Ob-R is comprised of six different isoforms (Ob-Ra-f), each derived from alternative 
mRNA splicing, resulting in identical leptin binding domains in the N-terminus, but different 
intracellular C-terminal domains (Myers et al, 2007; Zhou & Rui, 2013; Irving & Harvey, 2014). 
The isoforms of Ob-R can be further divided into three categories: long form (Ob-Rb), short form 
(Ob-Ra, Ob-Rc, Ob-Rd, and Ob-Rf), and secretory form (Ob-Re). Signal transduction is primarily 
mediated by Ob-Rb since it is the only isoform with the full-length intracellular domain required 
to mediate downstream signaling (Zhou & Rui, 2013; Irving & Harvey, 2014). Two major 
signaling cascades originating from Ob-Rb are the Janus kinase-2 (JAK2)/Signal Transducer and 
Activator of Transcription (STAT3) pathway and the insulin receptor substrate 
(IRS)/phosphoinositide-3-kinase (PI3K) pathway. In response to leptin, proximal membrane 
associated JAK2 phosphorylates tyrosine residue 1138 on the C-terminus of the Ob-Rb to cause 
the subsequent phosphorylation of STAT3 (Zhou & Rui, 2013; Irving & Harvey, 2014). 
Phosphorylated-STAT3 (p-STAT3) then influences the expression of genes, which alters energy 
expenditure, food intake and other related leptin-induced anti-obesity effects (Zhou & Rui, 2013; 
Irving & Harvey, 2014). Alternatively, in the IRS/PI3K signaling pathway, leptin induced 
phosphorylation of IRS results in phosphorylation of PI3K, which then acts on protein-kinase B 
(AKT/PKB) (Zhou & Rui, 2013; Irving & Harvey, 2014). AKT/PKB can then phosphorylate the 
Forkhead box protein O1 (FOXO1) transcription factor that acts to maintain nutritional 
homeostasis (Zhou & Rui, 2013; Irving & Harvey, 2014). See Figure 2 for a schematic of the 
aforementioned Ob-Rb signaling pathways.  
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Although the short forms of Ob-R are also involved with JAK/STAT signaling pathways, 
the majority of action from these receptors is primarily involved with leptin internalization and 
degradation (Gorska et al., 2010). Secretory Ob-Re acts as a buffering system for free circulating 
leptin in the blood, where it can either inhibit or enhance leptin signaling by delivering the bound 
leptin to the membrane bound isoforms to facilitate signaling (Gorska et al., 2010). At basal 
conditions, only about 5-25% of all isoforms of Ob-Rs are on the cell surface while the rest are 
within the cells (Gorska et al., 2010). The Ob-Rb and Ob-Ra isoforms, in addition to facilitating 
signal transduction, are internalized where they are degraded or recycled and returned to the cell 
surface after ligand binding (Gorska et al., 2010).  
2.3.2 Chronic Inflammation and Leptin Resistance 
During the onset of obesity, there are a number of factors that can contribute to the 
impairment of normal leptin signaling (Li et al, 2006; Martin et al., 2008). Firstly, proinflammatory 
cytokines produced from the accumulated adipocytes stimulate the liver to synthesize CRP, which 
can act as a serum-leptin-interacting protein that can bind to serum leptin (Li et al, 2006; Martin 
et al., 2008). Interestingly, leptin itself also promotes MCP-1 and CRP production in the liver by 
Kupffer and hepatic satellite cells, leading to even further impairments in leptin signaling (Li et al, 
2006; Martin et al., 2008). Leptin bound to CRP has reduced bioavailability and bioreactivity with 
Ob-Rb, ultimately resulting in reduced leptin receptor signaling, despite higher concentrations of 
circulating leptin (Li et al, 2006; Martin et al., 2008). Leptin could also be restricted from accessing 
Ob-Rb in the brain due to reduced expression of Ob-Ra, which is known to support the movement 
of leptin across the BBB (Li et al, 2006; Martin et al., 2008). As the body is exposed to chronic 
levels of high caloric intake and leptin production, Ob-Rb signaling may also be diminished 
through reduced trafficking of Ob-Rb as a compensatory mechanism (Li et al, 2006; Martin et al., 
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2008). Lastly, production of adipocyte-secreted inflammatory cytokines, such as IL-1 and IL-6, 
can also exacerbate the state of leptin resistance through interruption of downstream receptor 
signaling mediated by the JAK/STAT pathway with the expression of intracellular suppressor-of-
cytokine-signaling-3 (SOCS3) (Li et al, 2006; Martin et al., 2008). SOCS3 is normally produced 
as a negative feedback system in response to activation of the JAK/STAT pathway, but, in the case 
of inflammation, SOCS3 may be abnormally upregulated, resulting in an impaired leptin signaling 
process (Li et al, 2006; Martin et al., 2008). As a result, leptin resistance and inflammation continue 
to feed off of one another, resulting in many of the metabolic deficits that occur during obesity (Li 
et al, 2006; Martin et al., 2008).  
2.3.3 Leptin Resistance and Synaptic Plasticity  
The expression of the Ob-R is not limited to the hypothalamus; the Ob-R is also abundantly 
expressed on hippocampal and pre-frontal cortical neurons, and, as such, leptin resistance caused 
by obesity may modulate synaptic activity (Harvey et al, 2006; Irving & Harvey 2014). More 
specifically, the Ob-R has been shown to be expressed at the pre- and post-synaptic sites in the 
CA1 region of the hippocampus (Harvey et al., 2006). Excitatory signals among neurons are 
regulated primarily by glutamatergic signaling, especially through the ionotropic glutamate 
receptor subtype known as the N-methyl-D-aspartate (NMDA) receptor (Neves et al., 2012). 
Activation of NMDA receptors is critical for the induction of LTP (Neves et al., 2012). In genetic 
models, animals lacking functional Ob-Rs have impaired LTP in the CA1 region of the 
hippocampus, as well as impairments in spatial memory (Harvey et al, 2006; Irving & Harvey 
2014). As well, leptin administered to the hippocampus of rats resulted in improved memory 
performance, and promoted the conversion of short lasting potentiation into LTP (Oomura et al, 
2006; Harvey et al, 2006; Irving & Harvey 2014).  
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As noted, leptin activity is facilitated by PI3K, as well as the mitogen-activated-protein 
kinase (MAPK) signaling (Oomura et al, 2006; Harvey et al, 2006; Harvey, 2013; Irving & Harvey 
2014). In adults, the PI3K signaling pathway enhances the activity of GluN2A subunits of the 
NMDA receptor to promote rapid intracellular calcium cation influx (Harvey, 2013). In turn, this 
cation influx promotes the trafficking of another glutamate receptor, the alpha-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptor, to the synapse to promote long-lasting 
synaptic efficacy and enhanced LTP (Moult & Harvey, 2011). Moult & Harvey (2011) showed 
that bath application of leptin to adult rodent hippocampal slices resulted in increased cell surface 
expression of AMPA receptor GluA1 subunits. Surface expression of AMPA receptor GluA2 
subunits is also enhanced upon leptin application in the hippocampus, but a much higher 
concentration is required (Moult & Harvey, 2011). Together, these events also resulted in greater 
excitatory post-synaptic currents upon high frequency stimulation (Moult & Harvey, 2011). In 
addition, through the MAPK pathway, the growth of dendritic spines is stimulated by the rapid 
alteration in actin filaments in hippocampal neurons, which, in turn, lays the foundation to support 
continued LTP (Harvey et al, 2006; Irving & Harvey 2014). As such, with the development of 
leptin resistance, maintenance of synaptic plasticity may be impaired, which could lead to 
cognitive impairment (Oomura et al, 2006; Harvey et al, 2006; Harvey, 2013; Irving & Harvey 
2014). 
In relation to the effects of leptin resistance on the hippocampus as a result of diet-induced 
obesity, Valladolid-Acebes et al. (2013) found that 5 week old male C57BL/6L mice subjected to 
8 weeks of HFD experienced impaired hippocampal p-AKT/PKB signaling, but no difference in 
p-STAT3 signaling, relative to the CD animals, when given an acute intraperitoneal leptin 
administration. However no detriments were found between the groups when 8 week old male 
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mice were subjected to 8 weeks of the feeding protocol (Valladolid-Acebes et al., 2013). The age 
related difference was attributed to the varying stage of neuronal development and neurogenesis, 
suggesting that younger mice were more vulnerable to the effects of a HFD, while more drastic 
conditions may be required to develop the same degree of impairment in adults (Valladolid-Acebes 
et al., 2013).  
The results were comparable to Lu et al. (2011), who were able to show that a feeding 
protocol of 20 weeks with male mice resulted in a decrease in basal p-AKT/PKT protein expression 
and increased basal p-STAT3 protein expression relative to CD animals in the hippocampus even 
without leptin stimulation. Interestingly, the effects of a HFD in this study were mediated by a 20 
week oral administration of ursolic acid, an antioxidant with anti-inflammatory properties (Lu et 
al., 2011). Similarly, Camer et al. (2015) were also able to show a basal reduction in p-AKT/PKB 
protein expression along with reduced expression of BDNF and its related signaling components 
in both the hippocampus and the pre-frontal cortex in 12 week old male mice fed a HFD, providing 
further evidence that impaired leptin signaling can negatively impact synaptic plasticity. Like the 
previous study, the deficits they observed in their HFD feeding protocol were attenuated by co-
administration of another antioxidant with anti-inflammatory properties (bardoxoline methyl), 
indicating the important role of neuroinflammatory components earlier described (Camer et al., 
2015).  
2.4 Sexual Dimorphism in Response to a High-Fat Diet 
Neurophysiological studies that focus on biochemical mechanisms often examine 
phenomena in male animals only, creating a sex bias in the field (Beery & Zucker, 2011). While 
the characterization of diet-induced obesity on cognitive processes is still developing, this area of 
research is no exception (refer to Table 1). Importantly, sexual dimorphism exists in terms of the 
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development of obesity (Lovejoy et al., 2008; Palmer & Clegg, 2015). Men and post-menopausal 
women tend to accumulate fat in their abdominal depots, while pre-menopausal women tend to 
accumulate fat in their gluteal-femoral and subcutaneous depots (Lovejoy et al., 2008; Palmer & 
Clegg, 2015). In addition to differences in fat distribution, the fat mass developed in these different 
areas also exhibit different characteristics (Lovejoy et al., 2008; Palmer & Clegg, 2015). Visceral 
adipose tissue typically puts individuals more at risk of metabolic dysregulation and cardiovascular 
disease, as the hypertrophy of fat cells displays impaired leptin sensitivity and greater immune 
activation via elevated proinflammatory cytokine production (Lovejoy et al., 2008; Palmer & 
Clegg, 2015). In contrast, the expansion of subcutaneous adipose tissue via hyperplasia of 
adipocyte progenitor cells results in smaller adipocytes with greater sensitivity to insulin and leptin 
(Lovejoy et al., 2008; Palmer & Clegg, 2015). As a result, accumulation of subcutaneous adipose 
tissue actually exerts a protective effect against the metabolic irregularities that often result from 
diet-induced obesity (Lovejoy et al., 2008; Palmer & Clegg, 2015).  
 Differences between men and women in their fat development is mainly mediated by the 
gonadal hormone estrogen (Monteiro et al., 2014; Palmer & Clegg, 2015). Estrogen attenuates the 
accumulation of fat primarily through estrogen receptor alpha (ERα) by promoting lipolysis and 
enhancing adipose tissue sympathetic nerve activity (Monteiro et al., 2014; Palmer & Clegg, 
2015). As a result, differential distribution of ERα from neurons projecting into different fat depots 
results in the differences in fat build-up in different areas of the body between men and women 
(Monteiro et al., 2014; Palmer & Clegg, 2015). Estrogen also enhances energy expenditure by 
converting white adipose tissue to beige brown fat through the production of natriuretic peptides, 
which, in turn, results in adipose tissue that is more metabolically active (Monteiro et al., 2014; 
Palmer & Clegg, 2015). Lastly, estrogen deters the development of the low-grade inflammation 
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typically seen in obese individuals by mediating the production of hypoxia-inducible factor and 
preventing macrophage recruitment in the adipose tissue (Monteiro et al., 2014; Palmer & Clegg, 
2015).   
Due to the accumulated evidence for the protective effects of estrogen against obesity, it is 
therefore possible to assume that a HFD would affect male and female brains differently. Notably, 
Hwang et al. (2010) were able to demonstrate male animals fed a HFD were more susceptible to 
metabolic alterations, deficits in hippocampal-dependent learning, and impairments in the strength 
of LTP generated in the CA1 region of their hippocampus, relative to female animals. Sexual 
dimorphism in the response to HFD on synaptic plasticity was attributed to the lack of estrogen 
and ERα activity in the male animals providing protection against the effects of diet-induced 
obesity (Hwang et al., 2010). Jayarman et al. (2014) also highlighted the role of testosterone in 
neuroinflammation and neuronal viability as glial cultures from gonadectomized male mice 
displayed the greatest expression of TNFα and IL-1β mRNA expression when given a HFD. 
However, whether the neuroprotective effect of testosterone observed in this study was due to 
activity on its androgen receptor, or conversion into estradiol through aromatases as a means to 
mediate the inflammation remains unclear (Jayarman et al., 2014; Monterio et al., 2014). Taken 
together, results from these studies highlight the importance of gonadal hormone differences in 
response to a HFD, and how the brains of female and male animals are clearly affected differently 
by a HFD (Jayarman et al., 2014; Monterio et al., 2014).  
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Table 1: A Summary of High-Fat Diet Feeding Protocols  
Authors Species Sex Age of 
Animals  
(start of diet) 
High Energy Dietary 
Intervention 
Duration of 
Feeding 
Baumgarner et al. 
(2014) 
C57BL/6J mice Male 14 weeks 60% calories from fat 2-5.5 months 
Beilharz et al. 
(2014) 
Sprague-Dawley 
rats 
Male Not specified 
45% calories from fat 
with a 10% sucrose 
solution 
20-29 days 
Boitard et al. 
(2014) 
Wistar rats Male 3-12 weeks 45% calories from fat 2-4 months 
Camer et al. 
(2015) 
C57BL/6J mice Male 12 weeks 
Half lard, half  
sunflower oil 
21 weeks 
Hwang et al.  
(2010) 
C57BL/6J mice Both 3 weeks Not specified 8-11 months 
Kanoski et al. 
(2007) 
Sprague-Dawley 
rats 
Male 3 months 
40% calories from fat 
with either sucrose and 
dextrose supplement 
3 months 
Kanoski et al. 
(2010) 
Sprague-Dawley 
rats 
Male 2 months 40% calories from fat 3-4 months 
Lu et al. 
(2011) 
C57BL/6J mice Male 1 month 60% calories from fat 20 weeks 
Mielke et al. 
(2006) 
C57BL/6J mice Male Not specified 45% calories from fat 12 months 
Pistell et al. 
(2010) 
C57BL/6J mice Male 12 months 41-60% calories from fat 12-21 weeks 
Tucsek et al. 
(2014) 
C57BL/6J mice Male 7-24 months 60% calories from fat 5 months 
Valladolid-
Acebes et al. 
(2013) 
C57BL/6J mice Male 5-8 weeks 45% calories from fat 2 months 
 
Average Age of Animals (start of diet) 
 
5.42 months 
± 7.26  
Average Duration of 
Feeding 
5.25 months 
± 3.24 
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3.0 Study Rationale: 
In light of the molecular data illuminating the effects of an obesogenic diet on hippocampal 
and pre-frontal cortical function (Pistell et al., 2010; Valladolid-Acebes et al., 2013; Baumgarner 
et al., 2014; Boitard et al., 2014), I hoped to expand on what is known by examining the effects of 
a high-fat diet on markers of neuroinflammation and leptin signaling. In order to explore the sexual 
dimorphism in response to diet that is often neglected in neurophysiological studies, female 
animals were the focus of my experiments. 
I set the following objectives: 
1) Determine the effects of a high-fat diet on gliosis in female rat hippocampus and pre-
frontal cortex. GFAP acted as a marker of reactive astrocytes, while Iba-1 acted as a 
marker for activated microglia. 
2) Determine the effects of a high-fat diet on neuroinflammation in female rat hippocampus 
and pre-frontal cortex. In order to accurately survey the inflammatory milieu in the 
brain, a wide selection of cytokines was chosen: IL-1β was selected as a 
proinflammatory cytokine, IL-6 was selected as a pleiotropic cytokine, and IL-1ra and 
IL-10 were used as anti-inflammatory cytokines. 
3) Determine the effects of a high-fat diet on cellular expression of proteins involved with 
leptin signal transduction (Ob-R, AKT/PKB, p-AKT/PKB, STAT3) in female rat 
hippocampus and pre-frontal cortex. Since impaired leptin signaling may be due to 
either the reduced expression of Ob-R, or impaired transduction via the IRS/PI3K, or 
JAK/STAT pathways, levels of p-AKT/PKB, AKT/PKB and STAT3 were used as 
downstream markers of Ob-R signaling. 
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Based on the reviewed literature, I hypothesized that hippocampi and pre-frontal cortices 
from obese female rats would display elevated markers of neuroinflammation and gliosis. As a 
result, our animals would also exhibit reduced phosphorylation, or expression of signaling proteins 
involved with leptin signal transduction.  
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4.0 Materials and Methods  
4.1 Animals and Diets 
Experiments with animals were carried out in accordance with the guidelines for animal 
use issued by the University of Waterloo Animal Care Committee according to the protocols 
outlined by the Canadian Council of Animal Care. Sixty non-sibling female Sprague-Dawley rat 
pups were delivered at post-natal day 21 with foster mothers. On post-natal day 28, animals were 
randomly allocated to one of two feeding protocols for 10 weeks: a high-fat diet (HFD: n = 30; 
Catalogue #D12451, Research Diets Inc., New Brunswick, NJ, USA) consisting of 45% calories 
from saturated fat, or a control diet (CD: n = 30; Catalogue #D12450K, Research Diets Inc., New 
Brunswick, NJ, USA). See Table 2 for the full composition of the two diets. Animals were group 
housed (3 animals per cage), given ad libitum access to their respective diets and water, and were 
housed under a standard 12 hour light/dark cycle at a constant room temperature (23°C). Over the 
course of the experiments, body weights and food weights were recorded on a weekly basis. See 
Figure 3 for a summary of the feeding and experimental protocols.  
4.2 Oral Glucose Tolerance Test 
An oral glucose tolerance test (OGTT) was performed on a subset of animals (CD: n = 20; 
HFD: n = 20) after the first and second months of the diet by tracking the blood glucose levels 
from the tail vein over a course of 2 hours at 30 minute intervals following an oral gavage of a 
glucose bolus (2 g/kg of body weight).  
4.3 Sacrifice and Terminal Biometrics 
Around post-natal day 98, half of the experimental animals (CD: n = 15; HFD: n = 15) 
were anesthetized with CO2 and terminal body weights and naso-anal lengths were recorded. After 
euthanizing animals via decapitation, additional terminal biometric measurements (liver weight, 
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adrenal gland weight, spleen weight, and retroperitoneal fat pad weight) were recorded. Brain 
tissues were quickly extracted in artificial cerebrospinal fluid [124.0 mM NaCl, 3.0 mM KCl,  1.2 
mM NaH2PO4/H2O, 1.0 mM MgSO4/7H2O, 2.0 mM CaCl2/2H2O, 26 mM NaHCO3, 10 mM D-
Glucose, and 10 mM HEPES, equilibrated with carbogen (95% O2/5% CO2), pH 7.37-7.43]. 
Hippocampal and pre-frontal cortical tissues were then manually homogenized in non-ionizing 
lysis buffer [10 mM NaCl, 25 mM EDTA, 10 mM Tris, 1% (v/v) Triton X-100, 1% (v/v) NP-40] 
supplemented with a protease inhibitor cocktail [AEBSF, aprotinin, bestatin hydrochloride, E-64, 
leupeptin hemisulfate salt, and pepstatin A] and then centrifuged at 1000 x g for 10 minutes. 
Supernatants were then kept at -80°C until the point of analysis by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). The protein concentration of homogenates was 
determined using a BioRad DC protein assay kit and comparing the optical density of homogenates 
with a known concentration of bovine serum albumin. 
4.4 Immunoblotting Analysis 
Frozen hippocampal and pre-frontal cortical homogenates were thawed, and a total of 40 
µg of each homogenate was used for SDS-PAGE. Samples were denatured in an equal volume of 
sample buffer [125 mM Tris, 10% (v/v) glycerol, 4% (w/v) SDS, 10% (v/v) beta-mercaptoethanol, 
0.002% bromophenol blue, pH 6.8] at 95°C for 5 minutes before being separated 
electrophoretically (200 V at room temperature for 1 hour) with either a 10%, or 15% SDS-
polyacrylamide gel, depending on the molecular weight of the protein of interest. Afterwards, 
proteins were blotted onto polyvinylidene fluoride (PVDF) membranes via wet transfer (35 V at 
4°C overnight). Each membrane was then stained with Ponceau S solution to confirm that the 
protein transfer was successful, and then blocked with 5% (w/v) non-fat milk/tris-buffered saline 
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with Tween-20 (TBS-T) [20 mM Tris, 138 mM NaCl, 1% (v/v) Tween-20, pH 7.60] for 1 hour at 
room temperature.  
In order to probe for markers of gliosis, membranes were processed for GFAP (mouse 
monoclonal anti-GFAP, EMD Millipore, United States; 1:1000) and Iba-l (rabbit polyclonal anti-
Iba-1, Abcam PLC, United Kingdom; 1:200). For markers of neuroinflammation, membranes were 
processed for the proinflammatory cytokine IL-1β (rabbit  polyclonal anti-IL-1β, Santa Cruz 
Biotechnology, United States; 1:200), pleiotrophic cytokine IL-6 (mouse monoclonal anti-IL-6, 
Santa Cruz Biotechnology; 1:200), and anti-inflammatory cytokines IL-1ra (rabbit polyclonal anti-
IL-1ra, Santa Cruz Biotechnology; 1:200) and IL-10 (mouse monoclonal anti-IL-10, Santa Cruz 
Biotechnology; 1:200). For markers of leptin signaling, membranes were probed for Ob-R (mouse 
monoclonal anti-Ob-R, Santa Cruz Biotechnology; 1:200), STAT3 (rabbit polyclonal anti-STAT3, 
Santa Cruz Biotechnology; 1:200), and p-AKT/PKB (mouse monoclonal anti-p-AKT/PKB (Ser 
473) EMD Millipore; 1:1000), which was then reprobed for total AKT/PKB (mouse monoclonal 
anti-AKT/PKB, EMD Millipore; 1:1000). All blots were incubated with primary antibodies at 4°C 
overnight, followed by an incubation of 1 hour at room temperature with the appropriate enzyme-
linked secondary antibody (goat anti-rabbit, or anti-mouse, EMD Millipore; 1:2000). All solutions 
were prepared in 5% non-fat milk/TBS-T. Immunoblots were then incubated with enhanced 
chemiluminescence (ECL) substrate to activate the secondary antibody. SYNGENE was used to 
detect the luminescence with exposure lengths ranging from 30 seconds to 10 minutes. Optical 
density measurements were quantified using Adobe Photoshop CS6. In the event where a second 
trial was required for a specific blot due to distortion of a protein band, the usable data were 
averaged across the trials. 
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4.5 Statistical Analysis 
The data collected were stored in Microsoft Excel. Calculations were conducted in order 
to determine adjusted biometric measurements, such as BMI (body weight divided by naso-anal 
length2), percent liver weight (liver weight/body weight x 100%), percent spleen weight (spleen 
weight/body weight x 100%), percent adrenal gland weight (adrenal gland/body weight x 100%), 
spleen weight (spleen weight/body weight x 100%) and percent retroperitoneal fat pad weight 
(percent retroperitoneal fat pad weight/body weight x 100%). Body weight, BMI, liver weight, 
spleen weight, adrenal gland weight, and retroperitoneal fat pad weight were compared across 
dietary conditions using a two way unpaired Student’s t test in Graph Pad Prism.  
Background-subtracted optical density measurements for each band of interest were 
normalized to the total protein expression in each respective lane of an immunoblot (viewed with 
Ponceau S straining) with the exception of p-AKT/PKB expression, which was normalized to total 
AKT/PKB. A ratio was then constructed for each band by normalizing to non-experimental 
cortical tissue taken from CD males (that is, the internal control; IC).  The protein expression ratios 
were then used to compare the total hippocampal and pre-frontal cortical protein expression 
between the two dietary conditions using a Student’s unpaired t test in Microsoft Excel. In the 
event that an extreme outlier was suspected, Grubb’s test was applied. Differences with p <0.05 
were considered significant. 
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Table 2: Diet Composition 
 CD (D12450K) HFD (D12451) 
Composition %gram %kcal %gram %kcal 
Protein 19.2 20 24 20 
Carbohydrate 67.3 70 41 35 
Fat 4.3 10 24 45 
Total - 100 - 100 
kcal/gram 3.85 - 4.73 - 
 
Ingredients gram kcal gram kcal 
Casein, 30 Mesh 200 800 200 800 
L-Cystine 3 12 3 12 
Corn Starch 550 2200 72.8 291 
Maltodextrin 10 150 600 100 400 
Sucrose 0 0 172.8 691 
Cellulose 50 0 50 0 
Soybean Oil 25 225 25 225 
Lard 20 180 177.5 1598 
Mineral Mix 10 0 10 0 
DiCalcium 
Phosphate 13 0 13 0 
Calcium 
Carbonate 5.5 0 5.5 0 
Potassium Citrate, 
1 H2O 16.5 0 16.5 0 
Vitamin Mix 10 40 10 40 
Choline Bitartrate 2 0 2 0 
Red Food Dye 0.025 0 0.05 0 
Blue Food Dye 0.025 0 0 0 
Total 1055.05 4057 858.15 4057 
CD = control diet; HFD = high-fat diet 
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5.0 Results 
 
5.1 Body Weights and Food Intake 
 Mean food weights and body weights were monitored for all animals (CD: n = 30 animals; 
HFD: n = 30 animals) weekly over the course of the 10 week feeding period. No significant 
differences were found at the beginning of the experiment between HFD and CD animals (Figure 
4; t(58) = 0.54, p = 0.5945). HFD animals had a significantly higher body weight than CD animals 
at week 1 (t(58) = 1.44, p < 0.01), week 2 (t(58) = 3.00, p < 0.01), week 3 (t(58) = 2.12, p < 0.05), 
week 4 (t(58) = 2.07, p < 0.05), week 6 (t(58) = 2.00, p < 0.05), week 8 (t(58) = 2.06, p < 0.05), and 
week 10 (t(58) = 2.11, p < 0.05). 
In terms of food consumption (CD: n = 10 cages; HFD: n = 10 cages; 3 animals/cage), 
relative to CD animals, the HFD animals ate significantly more food at week 1 (Figure 5A; t(18) = 
3.53, p < 0.01) and then ate significantly less food at week 3 (t(18) = 4.99, p < 0.01), week 5 (t(18) 
= 3.92, p < 0.01), week 6 (t(18) = 3.30, p < 0.01), week 8 (t(18) = 3.35, p < 0.01), and week 9 (t(18) 
= 4.94, p < 0.01). In contrast, in terms of caloric intake, HFD animals consumed a significantly 
greater number of calories at week 1 (Figure 5B; t(18) = 7.76, p < 0.01), week 3 (t(18) = 2.43, p < 
0.05), week 4 (t(18) = 3.47, p < 0.01), week 5 (t(18) = 2.72, p < 0.05), week 6 (t(18) = 2.14, p < 0.05), 
week 7 (t(18) = 2.57, p < 0.05), week 8 (t(18) =3.90, p < 0.01), and week 9 (t(18) = 3.41, p < 0.01).  
5.2 Oral Glucose Tolerance Test 
 An oral glucose tolerance test (OGTT) was performed on a subset of animals from each 
diet after the first (CD: n = 18; HFD: n = 19) and second months of the diet (CD: n = 18; HFD: n 
= 18). Although the intended sample size was 20 animals per condition, due to unforeseen 
complications, an OGTT was not performed on two CD animals in month 1. Of the remaining 
animals, one animal of the HFD was excluded as a significant outlier. Similarly, OGTT was not 
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performed on two CD animals and two HFD animals in month 2. No significant differences 
between blood glucose levels was seen prior to the glucose bolus (Figure 6A; t(35) = 1.36, p = 
0.1777). Thirty minutes after glucose gavage, the HFD animals displayed a significantly higher 
blood glucose relative to CD animals (t(35) = 3.50, p <0.01; Effect Size = 1.17), which normalized 
by 60 minutes (t(35) = 1.71, p = 0.0967) and remained stable at 90 minutes (t(35) = 0.28, p = 0.7824) 
and 120 minutes (t(35) = 0.59, p = 0.5599). After the second month of the diet, no significant 
differences were seen prior to the glucose bolus (Figure 6B; t(34) = 0.11, p = 0.9132). After glucose 
gavage, HFD animals displayed a significantly elevated blood glucose level after 30 (t(34) = 3.16, 
p <0.01, Effect Size = 1.05) and 60 (t(34) = 2.11, p <0.05, Effect Size = 0.71) minutes, which 
normalized by 90 minutes (t(33) = 0.30, p = 0.7642) and remained stable at 120 minutes (t(34) = 
1.92, p = 0.0637).  
5.3 Terminal Biometric Analysis 
 Aggregated data from terminal biometrics collected from a subset of animals (CD: n = 15; 
HFD: n = 15) showing body weights, BMI, liver weight, spleen weight, adrenal gland weight, and 
retroperitoneal fat pad weight can be found in Figure 7(A) to (F), respectively. No significant 
differences were found between CD and HFD animal body weight (Figure 7A; t(28) = 1.59, p = 
0.1234), BMI (Figure 7B; t(28) = 0.46, p = 0.6511), liver weight (Figure 7C; t(28) = 0.14, p = 
0.8945), spleen weight (Figure 7D; t(28) = 1.55, p = 0.1320), or adrenal gland weight (Figure 7E; 
t(28) = 0.37, p = 0.7162). However, relative to CD animals, HFD animals had heavier 
retroperitoneal fat pads (Figure 7F; t(28) = 2.64, p < 0.05, Effect Size = 0.97).  
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5.4 Immunoblotting Housekeeping Data 
5.4.1 Transfer Efficiency 
 To confirm that my electroblotting conditions were sufficient to effectively transfer the 
proteins separated in the polyacrylamide gel onto the PVDF membranes, a Coomassie Brilliant 
Blue stain was applied onto the gels after the transfer. As seen in Figure 8, a wet transfer of 35 V 
for 16 hours at 4oC revealed limited protein staining throughout the gel, indicating that most 
proteins (with the exception of extremely high molecular weight ones) were removed from the 
polyacrylamide gel. A Ponceau S stain was also applied to the PVDF membrane after transfer. As 
seen in Figure 8, the transfer conditions were determined to be suitable, for the majority of proteins 
were transferred onto the PVDF membrane. 
5.4.2 Optimal Protein Concentration for Immunoblotting 
 In order to determine the amount of protein that would produce a clear signal without 
saturation, each antibody was characterized by probing against hippocampal tissue over a series of 
different protein concentrations. See Figure 9 for two sample protein loading characterization blots 
conducted for IL-1β and p-AKT/PKB. Based on the results from all the antibodies, 40 µg was 
determined to be generally optimal. 
5.4.3 Iba-1 Troubleshooting  
 Although Iba-1 was intended as a marker for microgliosis, despite examining a number of 
antibodies provided by various companies, a reliable signal could not be determined. Mouse 
monoclonal antibodies for Iba-1 from EMD Millipore (Catalogue #MABN92) and Santa Cruz 
(Catalogue #sc-32725) failed to yield a detectable signal even after loading up to 50 µg of tissue 
homogenate. A mouse monoclonal antibody (Catalogue #ab15690) and a rabbit polyclonal 
antibody (Catalogue #ab108539) for Iba-1 from Abcam were able to yield a detectable signal upon 
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loading 40 µg of tissue homogenate. However, when tested along with BV2, a microglial cell line 
used as a positive control, and MCF-7, a breast cancer cell line used as a negative control, the 
antibodies showed an unclear banding pattern (Figure 10). As a result, the decision was made to 
forgo probing for Iba-1 in the tissue samples.  
5.5 Hippocampal and Prefrontal Cortical Biochemical Analysis 
5.5.1 Expression of Gliosis Markers  
 To assess astrogliosis, a ratio of hippocampal (CD: n = 14; HFD: n = 15) and pre-frontal 
cortical (CD: n = 10; HFD: n = 10) protein expression of GFAP relative to an internal control (IC; 
non-experimental cortical tissue) was constructed. No significant differences were found between 
CD and HFD animals in either the hippocampus (Figure 11A; t(27) = 0.61, p = 0.5465), or the pre-
frontal cortex (Figure 11B; t(18) = 0.75, p = 0.4631). 
5.5.2 Expression of Neuroinflammatory Markers  
To assess neuroinflammation, a ratio of hippocampal (CD: n = 13-14; HFD: n = 15) and 
pre-frontal cortical (CD: n = 9-10; HFD: n = 10) protein expression of IL-1β, IL-6, IL-ra, and IL-
10 relative to IC was constructed. In the hippocampus, there were no significant differences in the 
expression of IL-1β (Figure 12A; t(26) = 0.83, p = 0.4162), IL-6 (Figure 12C; t(27) = 0.60, p = 
0.5550), IL-1ra (Figure 13A; t(27) = 1.73, p = 0.0945), or IL-10 (Figure 13C; t(27) = 0.30, p = 
0.7690) between CD and HFD animals. In the pre-frontal cortex, there was a significant increase 
in expression of IL-1ra (Figure 13B; t(17) =2.62, p < 0.05, Effect Size = 1.31) in HFD animals 
relative to CD animals. However there were no significant differences in the expression of IL-1β 
(Figure 12B; t(18) = 0.44, p = 0.6668), IL-6 (Figure 12D; t(18) = 0.76 p = 0.4596), or IL-10 (Figure 
13D; t(18) = 1.65, p = 0.1171) between CD and HFD animals.  
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5.5.3 Expression of Leptin Signaling Markers 
To assess components of the leptin signaling pathway, a ratio of hippocampal (CD: n = 14; 
HFD: n = 15) and pre-frontal cortical (CD: n = 9-10; HFD: n = 10) protein expression of Ob-R, 
AKT/PKB, p-AKT/PKB, and STAT3 relative to IC was constructed. In the hippocampus, HFD 
animals displayed a significant reduction in the expression of Ob-R (Figure 14A; t(27) = 2.26, p > 
0.05, Effect Size = 0.84) and AKT/PKB (Figure 15A; t(28) = 2.03, p < 0.05, Effect Size = 1.00) 
relative to the CD animals. However, no significant differences were found in the expression of 
STAT3 (Figure 14C; t(27) = 0.74, p = 0.4638)  and p-AKT/PKB (Figure 15C; t(27) = 0.74, p = 
0.4638) between CD and HFD animals. In the pre-frontal cortex, no significant differences were 
found in the expression of Ob-R (Figure 14B; t(17) = 1.08, p = 0.2973), STAT3 (Figure 14D; t(18) 
= 1.52, p = 0.1448), AKT/PKB (Figure 15B; t(18) = 0.44, p = 0.9657), and p-AKT/PKB (Figure 
15D; t(18) = 0.45, p = 0.6572) between CD and HFD animals. 
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6.0 Discussion 
In the present study, I examined the effects of a HFD consisting of 45% calories from 
saturated fat fed to female rats over a period of 10 weeks in order to identify potential 
neuroinflammatory and leptin signaling effects that could lead to cognitive impairment. The 
majority of the literature focuses on the neurological effects of HFD on male animals, leaving a 
noticeable gap that the current study tries to address considering sexual dimorphism in neural 
development and the development of obesity (Beery & Zucker, 2011). In addition, many 
researchers often fail to elaborate if their feeding protocol was successful at inducing an obese 
phenotype, and often use only changes in body weight as their indicator. Here, I studied an array 
of functional and biometric measures to assess whether the feeding protocol induced an obese 
phenotype.  
Our HFD animals displayed evidence of an impaired oral glucose tolerance based on a 
significantly higher blood glucose level 30 minutes after an oral glucose bolus following one 
month on the diet, and 30 and 60 minutes after a glucose bolus following two months on the diet. 
In addition, our female animals were significantly heavier after the 10 week feeding period. 
Despite the lack of significance, the HFD animals displayed a trend towards a higher body weight, 
and significantly heavier retroperitoneal fat pad weights. Based on all the findings, I concluded 
female animals fed the HFD had developed an obese phenotype.  
High-Fat Diet did not Affect Gliosis, but did Increase IL-1ra in the Pre-Frontal Cortex 
In spite of developing an obese phenotype, when I assessed the biochemical results from 
both the hippocampus and pre-frontal cortex, the HFD animals revealed no direct evidence of 
astrogliosis, or neuroinflammation as seen in the lack of alteration in GFAP and the array of 
cytokines examined. Even though Iba-1 was not explicitly probed, due to the reasons outlined in 
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Section 5.4.3, the lack of overt signs of neuroinflammation suggests that Iba-1 would most likely 
not be altered. Contrary to what was expected, in the pre-frontal cortex I observed an increased 
expression of the anti-inflammatory cytokine IL-1ra, indicating a possible reduction in 
neuroinflammation. The results were somewhat unexpected considering that the majority of the 
literature suggests the primary means of diet-induced cognitive impairment occurs through a 
neuroinflammatory model, where elevated expression of proinflammatory cytokines is detrimental 
to normal neuronal health and cognitive processes, such as plasticity (Lyman et al. 2014; Miller & 
Spencer, 2014). My results leave us with one of three possible explanations: 1) the pre-frontal 
cortex was in a state of neuroinflammation and the elevation of IL-1ra is indicative of a 
compensatory mechanism meant to return the brain to a state of basal inflammatory activity, 2) the 
lack of neuroinflammation suggests that female animals are inherently more resistant to the effects 
of HFD feeding, or 3) although an obese phenotype was reached in our animals, the duration of 
the feeding period, or the fat content in our diet was not sufficient to induce neuroinflammatory 
effects.  
To address the first explanation, while I did not observe direct evidence of 
neuroinflammation via changes in the level of proinflammatory IL-1β, or pleiotropic IL-6, 
elevation in IL-1ra in the pre-frontal cortex could suggest a compensatory effect in response to an 
earlier state of diet-induced neuroinflammation. While not significant, HFD animals also displayed 
a trend towards elevated anti-inflammatory IL-10 production in the pre-frontal cortex. The 
difference between the two regions of the brain in terms of their inflammatory activity was 
surprising since the hippocampus and pre-frontal cortex have comparable levels of microglia and 
astrocytes in healthy adult rodents based on comparisons between different brain region cell 
densities determined via immunohistochemistry targeting specific glial markers (Lawson et al., 
50 
 
1990; Savchenko et al., 1997). This would suggest that these two brain regions would also share a 
similar cytokine profile. Furthermore, when LPS is used to elicit an immune response in neuronal-
glial cultures derived from these two brain regions, they show comparable level of TNFα and nitric 
oxide production, suggesting the microglia from these two regions show comparable activity (Kim 
et al., 2000).   
Instead, my results may suggest that the brain is differentially affected, potentially due to 
the dietary intervention causing a shift in microglial residency and activity because glial 
distribution is primarily mediated by environmental cues (Lawson et al., 1990). More specifically, 
the microglia in the pre-frontal cortex may be shifting towards an alternatively activated (M2) 
phenotype rather than the classically activated (M1) phenotype (Eggen et al., 2013; Kraakman et 
al., 2014). M1 macrophages and microglia are typically involved with the enhanced expression of 
proinflammatory mediators as seen during states of inflammations while the M2 subsets are 
typically involved with tissue recovery and counteracting inflammation (Eggen et al., 2013; 
Kraakman et al., 2014). During chronic inflammation and obesity, macrophages recruited in the 
adipose tissue shift towards the M1 phenotype leading to adipose tissue dysfunction and impaired 
glucose tolerance (Kraakman et al., 2014). However, populations of macrophages are dynamic, 
and prolonged exposure to a HFD can cause macrophages to subsequently increase expression of 
M2 associated transcripts (Kraakman et al., 2014). Similarly, during certain cases of infection, 
microglia initially adopt the M1 phenotype to clear the pathogen, and then shift to more of an M2-
like phenotype (Kraakman et al., 2014). In addition, microglia are also adaptive in their 
development, where repeated or chronic systemic inflammation can lead to either sensitization 
(leading to greater proinflammatory response to subsequent immune stimulation), or innate 
immune tolerance, where microglia develop an attenuated immune response to protect against 
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neuronal damage (Kraakman et al., 2014). Based on the imbalance in the cytokine profile that was 
observed, it is likely a combination of both M2 polarization and immune tolerance may be 
occurring in the microglia in the pre-frontal cortex of our HFD animals as a compensatory effect.   
Elevated IL-1ra in this region of the brain most likely reflects the high IL-1ra to IL-1β ratio 
necessary to counteract the inflammatory effects of IL-1β (Arend 2002). IL-1ra is the natural 
antagonist to IL-1 signaling, and by binding to its functional receptor, IL-1 receptor type 1 (IL-
1R1), blocks its ability to initiate downstream signaling (Arend 2002). Even in the event of 
infection in healthy adults, IL-1ra concentrations in the circulation must exceed IL-1 by 
approximately 100 fold in order to negate the effects of IL-1 on target tissues due to the presence 
of decoy receptors with no signaling properties such as IL-1 receptor type 2 (IL-1R2) (Arend 
2002). Furthermore, imbalance between IL-1β and IL-1ra in our animals is consistent with the 
serum cytokine milieu of individuals with obesity and type II diabetes mellitus, where IL-1ra is 
elevated in addition to various proinflammatory mediators (Arend et al., 2002; Herder et al., 2009; 
Donath & Shoelson, 2011). In fact, obese individuals suffering from hyperleptinemia display a 
level of IL-1ra in their serum that is 7 times greater than that observed in the serum of health weight 
controls (Juge-Aubry et al. 2003). Elevated IL-1ra may have a role in improving insulin signaling 
as exposure to IL-1β has been shown to be detrimental and injurious to β-cell function in the 
pancreas (Arend et al., 2002; Herder et al., 2009; Donath & Shoelson, 2011). As a result, elevated 
IL-1ra is highly indicative of  pre-diabetes, where the body is in a state of subclinical inflammation, 
and may operate as a means to improve glycemic control (Herder et al., 2009; Donath & Shoelson, 
2011). Considering that IL-1ra can also cross the BBB and can be produced centrally by glial cells 
in the CNS, it is plausible that the pre-frontal cortical cytokine profile I observed in our HFD 
animals is similar to the inflammatory profile of diabetics (Arend 2002; Herdder et al., 2009; 
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Donath & Shoelson, 2011). On the other hand, unlike the pre-frontal cortex, I did not observe 
difference in IL-1ra expression in the hippocampus. However, the pre-frontal cortex and the 
hippocampus are intimately connected, and, as a result, an altered immune state in the pre-frontal 
cortex could lead to dysfunction of hippocampal function (Preston & Eichenbarum, 2013). 
Behavioural data from Goshen et al. (2007) supports such a relationship as mice in their study 
given an intracerebroventricular administration of a high exogenous dose of IL-1ra (100 µg) 
showed significantly reduced hippocampal-dependent learning processes such as fear conditioning 
to a specific context.  While I did not measure IL-1ra, or insulin levels in the periphery to support 
that our animals were in a diabetic state, the impaired OGTT that I observe in our HFD appears 
consistent with the theory.  
An alternative explanation to the compensatory effect of diet-induced neuroinflammation 
is the possibility that female animals are more resistant to the effects of the HFD as estrogen does 
exert a regulatory effect on metabolic inflammation by promoting lipolysis, reducing macrophage 
infiltration of adipose tissue, and supressing the proinflammatory action of IL-6 and TNFα to 
mitigate potential tissue damage (Lovejoy et al., 2008; Palmer & Clegg, 2015; Moneterio et al., 
2014). The regulatory effects on metabolic inflammation of estrogen signaling are primarily 
mediated by activity on its non-nuclear receptors, as opposed to classical genomic estrogen 
signaling that regulates reproductive effects (Monterio et al., 2014). Along with the anti-
inflammatory effects of estrogen, acute 17 β-estradiol application also has a role in promoting LTP 
in the CA1 region of the hippocampus in both male and female animals (Foy et al., 2010). Pre-
treatment of 17 β-estradiol has also been shown to induce protection against NMDA-mediated 
excitotoxicity in both cultured neurons and hippocampal slices (Foy et al., 2010). Together, these 
findings suggest that female animals may be more resistant towards not only the metabolic effects 
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of a HFD, but also resistant to potential neuroinflammation processes that would be detrimental to 
synaptic plasticity (Foy et al., 2010; Moneterio et al., 2014). As mentioned earlier, confirming 
whether an inflammatory cytokine profile is occurring in the periphery of our animals would help 
to determine whether the animals were indeed protected. Future studies will need to directly 
examine sexual dimorphism with male animals, or ovariectomized female animals, fed using the 
same feeding protocol.  
To address the last possibility, I compared our feeding protocol to those of other studies. 
Our feeding protocol was modest compared to the one used by Pistell et al. (2010), where animals 
fed a diet with 60% of calories from fat over 16 weeks revealed gliosis and elevated 
proinflammatory cytokine expression. Beilharz et al. (2014) used a HFD similar to ours and fed 
for a shorter period of time (45% kcal from fat fed over 27-29 days), but supplemented their HFD 
with a 10% sucrose solution, which could potentially account for the fact they observed elevations 
in hippocampal TNFα and IL-1β mRNA in their animals. Notably, the one comparable study in 
terms of both content and duration (45% kcal from fat fed over 4 months), Boitard et al. (2014) 
found no differences in cytokine mRNA levels under basal conditions, but did observe enhanced 
inflammatory cytokine mRNA expression upon stimulating the animals with an immune challenge 
(intraperitoneal injection of LPS). An alternate form of an immune challenge that is also effective 
at stimulating cytokine expression is the administration of viral mimics like polyriboinosinic-
polyribocytidylic acid (PIC) (Konat et al., 2011; Krstic et al., 2012). However, given that PIC 
activates the immune system through TLR3 activation, rather than TLR4 activation like that of 
saturated fatty acids, LPS would be a better candidate for an immune challenge due to its homology 
in immune stimulation (Konat et al., 2011; Krstic et al., 2012). Regardless, had an immune 
challenge of either LPS, or PIC been applied, I may have been able to see a difference in 
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proinflammatory cytokine expression, where the HFD animals may have displayed a greater 
neuroinflammatory response despite showing no differences in basal proinflammatory cytokine 
expression.  
The technique used to measure cytokine expression also needs to be considered. The 
majority of the literature that analyses cytokine expression typically assesses mRNA expression 
via quantitative reverse-transcription polymerase chain reaction (qRT-PCR), or protein expression 
via enzyme-linked immunosorbent assay (ELISA) (Pistell et al., 2010; Baumgarner et al., 2014; 
Beilharz et al., 2014; Boitard et al., 2014). Only a small proportion of studies examined cytokine 
profiling via immunoblotting as I have. In spite of this, Lu et al. (2001) were able to show that a 
HFD feeding protocol was capable of inducing a neuroinflammatory state. HFD mice from their 
study displayed greater protein expression of proinflammatory TNFα and IL-2, a cytokine which 
regulates the activity of leukocytes. However, their more extensive feeding protocol (20 weeks of 
a HFD consisting of 60% saturated fat) may indicate that a more intensive dietary intervention is 
required to induce similar effects in our female animals (Lu et al., 2011).  
When quantifying mRNA expression using qRT-PCR, mRNA is often used as a proxy for 
the abundance of proteins in a biological sample despite the fact that the relationship between 
mRNA and protein level is not always linear (Maier et al., 2009). Translation efficiency of mRNA 
into proteins can be affected by several factors, such as the structure of mRNA, differences in the 
distribution of mRNA translational regulatory proteins, codon bias, and ribosomal density, while 
post-translational factors such as protein stability, localization of protein, and post-translational 
modification, such as ubiquitination, can affect protein abundance and turnover (Maier et al., 
2009). Therefore, despite the data presented by earlier reports (Baumgarner et al., 2014; Beilharz 
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et al., 2014; Boitard et al., 2014), the possibility exists that cytokine protein expression may not 
actually be affected by a HFD.  
Instead of quantifying mRNA, expression of cytokine proteins is most commonly analyzed 
using the sandwich ELISA technique (Amsen et al., 2009). In this variant of ELISA, homogenates 
are added to microtiter wells, so that embedded antibodies specific for the cytokines become 
immobilized (Amsen et al., 2009). A second enzyme-linked antibody is then added to the cytokine 
complex, which can be chemically converted to produce a colour change (Amsen et al., 2009). The 
intensity of the colour change is then considered to be proportional to the amount of cytokines 
present in the homogenate (Amsen et al., 2009). While ELISAs are highly sensitive and high 
throughput, any technique that utilizes an antibody-antigen interaction does risk a non-specific 
antibody-antigen reaction, where proteins besides the targeted cytokine bind to the antibodies, 
resulting in a false positive (Amsen et al., 2009). Immunoblotting offers higher specificity in this 
regard since homogenates are first separated by weight to aid in the isolation and visualization of 
the target protein brand (Porsh-Ozcurumez et al., 2004; Chou et al., 2005). For example, to 
diagnose individuals suspected of being infected with Francisella tularensis, the bacterium 
responsible for tularemia, or human immunodeficiency virus, ELISA is often used as an initial 
screening tool followed by immunoblotting for confirmation (Porsh-Ozcurumez et al., 2004; Chou 
et al., 2005).  
High-Fat Diet impaired Ob-R and AKT/PKB expression in Female Rat Hippocampus 
Our HFD reduced the expression of certain proteins related to leptin signal transduction in 
the hippocampus, but not the pre-frontal cortex (a trend towards a reduced Ob-R expression was 
observed, but was non-significant). Although the observed deficits were modest, my results 
suggest that reduced Ob-R and AKT/PKB expression in response to a HFD may be a compensatory 
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mechanism to leptin overexposure, and, as a result, may have led to impaired leptin signaling in 
the hippocampus along the IRS/PI3K pathway. The results are in agreement with the conclusions 
from previous HFD feeding studies conducted by Valladolid-Acebes et al. (2013) and Lu et al. 
(2011), who found most of their deficits along the IRS/PI3K pathway, rather than the JAK/STAT 
pathway, in the hippocampus. However, their deficits were attributed to the phosphorylation of 
AKT/PKB being reduced rather than AKT/PKB expression (Lu et al., 2011; Valladolid-Acebes et 
al., 2013). As previously mentioned, Lu et al. (2011) used a more extensive diet regimen compared 
to ours, and Valladolid-Acebes (2013) stimulated their animals with an acute leptin injection in 
order to examine differences at the level of phosphorylation. If I were to apply leptin onto brain 
slices prepared from our animals, further deficits in leptin signaling may be observed, and provide 
further evidence on how synaptic plasticity could be affected. AKT/PKB is also shared with many 
other signaling cascades, such as the insulin signaling pathway and tropomyosin receptor kinase 
(TrkB) signaling, which is activated by BDNF (Camer et al., 2015). As such, a reduced expression 
of AKT/PKB may imply that a deficit is also occurring at these levels to further reduce 
hippocampal function and neuronal health, although additional markers from these signaling 
cascades, such as TrkB or insulin receptor phosphorylation, should be used to confirm this 
possibility. Similar to the work that is required to clarify cytokines signaling, leptin levels and 
proteins involved with leptin signal transduction should also be examined in the periphery to 
confirm if there is indeed elevated serum leptin leading to systemic leptin resistance. Considering 
that leptin signaling is also involved in stimulating the production of proinflammatory mediators, 
it would also be of interest to probe for acute phase proteins, such as CRP, which has been 
previously found to hamper leptin signaling (Li et al., 2006; Martin et al., 2008).  
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Maternal High-Fat Diet and Effects on Offspring 
In addition to filling the gap in the literature in regards to how female brain responds to a 
HFD, studying female animals provided the means to study another important aspect of obesity. 
As more individuals continue to develop obesity worldwide, so too does the number of obese 
women of reproductive age. Considering the developmental origins of health and disease in 
reference to obesity, a HFD could potentially act as a type of nutritional stress that can permanently 
alter fetal physiology through the process of developmental programming (Gluckman & Hanson, 
2004; Calkins & Devaskar, 2011). Altered hormonal and metabolic effects exerted by maternal 
HFD may influence early brain development via fetal neuronal modulation (Gluckman & Hanson, 
2004; Calkins & Devaskar, 2011). Here, I demonstrated a reduction in Ob-R and AKT/PKB 
expression in the hippocampus and elevated IL-1ra expression in the pre-frontal cortex in our 
female animals, which may indicate an altered hormonal and metabolic state that could influence 
early brain development. Behavioural evidence for the transgenerational effect of diet can be seen 
in a study conducted by White et al. (2009), where offspring from HFD mothers performed worse 
on the Morris water maze over the course of 8-9 trials in terms of latency and distance traveled to 
reach the hidden platform, indicating a deficit in memory retention over the training days. The 
effect was amplified and revealed a significant difference once the offspring themselves were 
given a HFD (White et al., 2009).  
In terms of neuroinflammation, studies have shown that a maternal diet can have effects 
on the brain cytokine milieu of the fetus during embryonic development, producing pups with 
greater levels of activated microglia, leading to detrimental effects on normal neurodevelopment. 
White et al. (2009) demonstrated that a maternal HFD alone was sufficient to induce significantly 
elevated levels of IL-6 protein expression in 20 week old pups, while offspring diet was sufficient 
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to induce an enhanced level of glial activity with elevations in GFAP and Iba-1 protein expression, 
with no differences found in the level of BDNF and MCP-1. Bilbo & Tsang (2010) have shown 
that the hippocampus of HFD pups showed significantly higher basal levels of IL-1β protein 
expression compared to low-fat diet pups that persisted until adulthood. HFD pups also displayed 
greater hippocampal IL-1β expression in response to an intraperitoneal LPS injection compared to 
the low fat diet pups (Bilbo & Tsang, 2010). The effect was significantly more pronounced in male 
pups relative to female pups upon reaching adulthood (Bilbo & Tsang, 2010). The results also 
coincided with cytokine expression in the periphery, with HFD pups being more sensitive to the 
LPS immune challenge, and heightened liver IL-1β and serum IL-6 expression compared to 
immune stimulated, low-fat diet pups (Bilbo & Tsang, 2010). 
As for leptin signaling, Kuang et al. (2014) were able to show that two month old pups 
born from mothers fed a high-sucrose diet showed significant impairments in PI3K and p-
AKT/PKB protein expression, and histological evidence demonstrated elevated levels of apoptosis 
occurring in the CA1, CA2, and CA3 regions of the hippocampus. In this study, the authors 
concluded that PI3K and p-AKT/PKB, signaling molecules that are downstream to both leptin and 
insulin-like growth factor-1 (IGF-1), seemed to have neuroprotective effects by limiting the 
production of caspases and mediating the production of anti-apoptotic factors (Kuang et al., 2014). 
Limitations  
 There are several limitations to consider when interpreting the results I have displayed.  
As previously mentioned, HFD protocols in terms of fat content and feeding duration are rather 
variable, making the connection of past literature with my results difficult. In addition, strain 
differences in the animals used may also play a factor in the difference response to HFD (Jun & 
Fen, 2006; Kucera & Cervinkova, 2014). Male Sprague-Dawley rats, for example, have been 
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shown to be more resistant to the effects of a HFD compared to male Wistar rats. When given the 
same HFD (45% kcal from fat), Wistar rats displayed significantly heavier body weights, impaired 
oral glucose tolerance, and enhanced lipogenesis compared Sprague-Dawley rats even when the 
latter strain is fed the HFD for a longer period of time (11 weeks vs. 7 months) (Jun & Fen, 2006). 
However, other studies have shown Sprague-Dawley rats, especially male animals, are more 
susceptible to non-alcoholic fatty liver disease induced by HFD consumption compared to Lewis 
and Wistar rats based on the degree of liver fibrosis and hepatic damage (Kucera & Cervinkova, 
2014). Taken together, results from these studies indicate that not only do animal strains respond 
differently to HFD, but that they could also display different immune profiles as a result. 
Consequently, our findings in the hippocampus and pre-frontal cortex may be specific only to 
female Sprague-Dawley rats.   
Another limitation that was previously mentioned is the lack of peripheral metabolic 
measures in relevant biomarkers in the blood serum of our animals. Any potential effects of 
neuroinflammation and impaired leptin signaling in the brain as a result of HFD would presumably 
originate in the periphery (Irving & Harvey, 2014; Miller & Spencer, 2014). Therefore, examining 
cytokine, leptin, and insulin expression in the serum would strengthen the interpretation of the 
mechanism behind HFD induced impairments.  
 Lastly, one final limitation to consider is the limited power to detect an effect in many of 
the protein expression experiments. Post-hoc power analysis of the immunblotting results reveals 
low power, ranging from 0.03 to 0.41. Since the power calculated is less than the convention of 
0.8, the current study design is considered to have insufficient power, and runs the risk that we 
may falsely accept the null hypothesis (committing a Type II error) (Onwuegbuzie & Leech, 2004). 
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Therefore, future studies may benefit from the inclusion of more animals to ensure sufficient 
power.  
Conclusion and Future Directions 
 In this study, I found that female rats fed a HFD over a 10 week period resulted in potential 
compensatory mechanisms in response to neuroinflammation (characterized by elevated IL-1ra 
expression in the pre-frontal cortex) and to leptin overexposure (characterized by reduced 
expression of Ob-R and AKT/PKB). Taken together, these physiological changes suggest that our 
animals may be predisposed to cognitive deficits as both these factors can contribute to impaired 
synaptic plasticity. To explore the potential role of estrogen mitigating neuroinflammatory deficits 
in the CNS, I hope to include male animals in the future to allow for a direct sex comparison. In 
addition, some of the differences characterized in the literature were not as prominent in our 
animals, and may require additional treatment (such as LPS injection, or leptin application) to 
allow differences that may not have been observed at basal levels to be observed. Lastly, to explore 
the effects of maternal diet on offspring, an additional future experiment could examine the 
presence of similar protein expression changes in the brains of offspring.  
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